Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0300
-0.0020 (-6.25%)
Jun 19, 2026, 3:51 PM AEST
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 48.95 million as of June 18, 2026. Its market cap has increased by 3.10% in one year.
Market Cap
48.95M
Enterprise Value
43.20M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 48.95M, an increase of 28.62%. That is a compound annual growth rate of 13.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 48.95M | -4.88% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 87.03M |
| Immutep | 72.21M |
| Prescient Therapeutics | 71.50M |
| Radiopharm Theranostics | 70.88M |
| Cynata Therapeutics | 63.30M |
| Amplia Therapeutics | 61.60M |
| Botanix Pharmaceuticals | 60.15M |
| Avecho Biotechnology | 53.63M |